Full-Time

Dosimetrist 1

Proton Therapy

Posted on 10/13/2025

Deadline 1/31/26
Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center

1,001-5,000 employees

Nonprofit cancer treatment, research, and trials

Compensation Overview

$70 - $117/hr

No H1B Sponsorship

Seattle, WA, USA

In Person

Relocation assistance may be available.

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Bachelors degree preferred, specifically in Radiation Therapy, Math, or Physics.
  • Must be a graduate of a JRCERT accredited medical dosimetry program or have at least 2 years of on the job training as a medical dosimetrist.
  • Must be board eligible in Dosimetry as recognized by MDCB.
  • Excellent communication skills are essential.
  • May be required to lift, carry or push up to 40lbs.
Responsibilities
  • Perform external beam radiation therapy planning procedures and dose calculations. Planning utilizes CMS XiO and Monaco; a 3-D planning system proprietary to Elekta.
  • Perform high dose radiation therapy (HDR) planning procedures and dose calculations. Planning utilizes BrachyVision; a planning system proprietary to Varian.
  • Use Mosaiq as EMR and other associated software to accomplish this end.
  • Work with physicians, residents, physics, therapists and other RadOnc staff to ensure the patients plan and treatment are simulated, planned and treated in a dosimetrically appropriate and efficient manner.
  • Follow Physician directives to create radiation plans using the treatment planning software(s) and present resultant dosimetry plan.
  • Assist in Simulation process with Therapists/Physicians/Physicists as requested.
  • Perform charge capture for procedures performed. Execute reconciliation of charges with documentation in EMR.
  • Assists medical physicist in calibration of equipment and radioactive
  • Dosimetrist will conduct quality assurance reviews, and conduct quality checks on various equipment.
  • Develops computerized treatment plan, calculates treatment doses and / or monitor unit setting to deliver dose to a tumor volume as prescribed by a radiation
  • Calculates and documents dose in the patient’s MOSAIQ electronic treatment
  • Verifies the mathematical accuracy of all
  • Assists in the selection, planning, fabrication and quality review and approval of treatment devices to aid in beam delivery
  • Assists in the planning, production and quality review and approval of immobilization devices and other treatment
  • Provides technical assistance to the therapeutic radiological physicist in radiation
  • Performs weekly quality assurance checks of radiotherapy treatment
  • Follows all policies and procedures established for the accurate, timely and effective development and QA of all dosimetry responsibilities.
  • Responsible for thorough and timely documentation and coding of work in the EMR and
  • Implements and assists in the maintenance of the quality system for medical dosimetry and record
  • Participates in quality check lists as source of intra-center
  • May act as teacher/instructor during orientation phases of new dosimetry
  • Ensures that all procedures are followed, verified and QA’d as they relate to the outsourcing or treatment devices, acceptance of said devices at Fred Hutch, and implementation of said devices during patient treatment.
  • Adheres to treatment protocol standards established by Seattle Proton Center for specific disease sites/stages/fields and ensures that documentation is thorough and captured
  • Participates in the development and/or implementation of new techniques as assigned by Dosimetry Manager.
Desired Qualifications
  • Board certified preferred, and if not, must be board eligible. If not certified, certification as a Medical Dosimetrist by the MDCB is required within 1 years of becoming a Medical Dosimetrist at our facility.
  • Prior experience with the following equipment is a plus:
  • Elekta CMS XiO and Monaco Treatment Planning Systems
  • Mosaiq EMR software
  • Varian BrachyVision Treatment Planning System
  • MU Check Secondary Calculation Software
  • Elekta Simulator
  • Elekta Accelerators: Synergy & Infinity with Agility heads
Fred Hutchinson Cancer Center

Fred Hutchinson Cancer Center

View

Fred Hutchinson Cancer Center is a nonprofit cancer treatment and research institute serving the Pacific Northwest and beyond. It provides a full range of cancer care, including treatments that may not be available elsewhere, and offers patients the chance to participate in clinical trials. The center accomplishes its work through a combination of patient care, research grants, and fundraising, and collaborates with UW Medicine and other regional providers to extend its reach. Internationally, it operates facilities in Uganda and South Africa to advance research and collaboration. The organization’s revenue comes from patient services, grants, and fundraising events. Its central goal is to eliminate cancer and related diseases by improving treatments and ultimately finding a cure.

Company Size

1,001-5,000

Company Stage

Grant

Total Funding

$300K

Headquarters

Seattle, Washington

Founded

1975

Simplify Jobs

Simplify's Take

What believers are saying

  • Ai2, Google Cloud add $20M to Cancer AI Alliance's $40M funding.
  • Global sites in Uganda, South Africa enable diverse AI training data.
  • NCI-designated center since 1973 drives research grants, fundraising.

What critics are saying

  • AWS, Microsoft, NVIDIA cut commitments, halting 2025 AI results.
  • Dana-Farber, MSK erode Fred Hutch's precision oncology referrals.
  • NIH grants lapse, Obliteride donors drop in recession by 2027.

What makes Fred Hutchinson Cancer Center unique

  • Fred Hutch leads Cancer AI Alliance coordinating Dana-Farber, MSK, Johns Hopkins.
  • Offers 750+ active clinical trials, most in Pacific Northwest.
  • Pioneers precision oncology via Stuart and Molly Sloan Institute.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Paid Vacation

Paid Sick Leave

Paid Holidays

Paid Parental Leave

Sabbatical Leave

Tuition Reimbursement

Company News

GeekWire
Apr 17th, 2025
Tech Moves: Smartsheet Names Chief Product Officer; Meta Vet Joins Tech Alliance; And More

Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Arora. (Smartsheet Photo)— Pratima Arora has been named chief product officer at Smartsheet, a new senior executive role at the Bellevue, Wash.-based enterprise software giant.A longtime product and technology leader, Arora will be responsible for Smartsheet’s product management, product marketing, user experience, pricing and packaging, and digital and product partnerships.She previously held senior leadership roles at Atlassian and Salesforce, and was most recently the chief product and technology officer at Chainalysis.“After a fantastic 4-month break to recharge, spend quality time with family, and dive deep into the world of GenAI, I’m energized and ready for what’s next,” Arora said on LinkedIn. “There’s no better place than Smartsheet to begin this new chapter. With a strong foundation, a passionate customer base, and a unique opportunity to reimagine collaborative work through AI, the road ahead is full of possibility.”Smartsheet also announced that Nick Dunn, an eight-year veteran of the company, is now general counsel, responsible for leading the company’s legal, privacy, and risk functions, including corporate governance initiatives.Launched in 2005, Smartsheet makes cloud-based enterprise work management technologies for managing and tracking projects, collaborating, storing data, and automating and assigning tasks, among other capabilities. It serves 85% of the Fortune 500 as customers

PR Newswire
Apr 4th, 2025
Google Cloud And Ai2 Commit $20M To Advance Ai-Powered Research For The Cancer Ai Alliance

Google Cloud to provide advanced and secure technology, while Ai2 to lead AI training and development for AI cancer modelsSEATTLE and SUNNYVALE, Calif., April 4, 2025 /PRNewswire/ -- Today, Google Cloud and Ai2 announced they have partnered with the Cancer AI Alliance (CAIA), a pioneering consortium uniting leading cancer research institutions and technology companies to harness artificial intelligence (AI) in the fight against cancer. Google Cloud and Ai2 are each giving $10 million to the initiative and providing access to technology solutions that will help speed scientific discovery. Google Cloud will power planet-scale AI infrastructure and data analytics tools, while Ai2 will provide critical expertise in training large-scale models focusing on cancer research

GeekWire
Apr 4th, 2025
Ai2 And Google Cloud Join Cancer Ai Alliance With A Total Of $20M In Commitments

Inside the Allen Institute for AI in Seattle. (GeekWire File Photo / Todd Bishop)The Allen Institute for AI (Ai2) is joining a high-profile national effort to accelerate cancer research using artificial intelligence, committing $10 million in researcher time and technical expertise to the Cancer AI Alliance, a consortium led by the Fred Hutch Cancer Center.Google Cloud is also committing $10 million in resources to the effort, planning to provide computing infrastructure and tools to help process large volumes of cancer data. They say the goal is to create a novel AI infrastructure that supports the training and deployment of AI models across institutions while maintaining data security and privacy standards for patients.The Cancer AI Alliance was announced in October 2024 as a joint effort among four major cancer centers: Fred Hutch, Dana-Farber, Memorial Sloan Kettering, and Johns Hopkins. Backed by more than $40 million in initial support from AWS, Microsoft, NVIDIA, Deloitte, and Slalom, the project aims to use artificial intelligence to analyze large volumes of cancer data across institutions. Seattle-based Fred Hutch is serving as the lead coordinating center.Ai2 CEO Ali Farhadi in his Seattle office. (GeekWire File Photo / Todd Bishop)In a previous interview with GeekWire, Ai2 CEO Ali Farhadi said the Cancer AI Alliance represents the kind of real-world challenge that needs customized, domain-specific AI models. The Seattle-based AI institute focuses on open-source artificial intelligence technologies.Farhadi said Ai2’s role in the Cancer AI Alliance reflects Ai2’s goal to apply cutting-edge research where it can have the most tangible impact on the world.“Any step in the right direction in that space is going to be a risk worth taking, and that’s the kind of impact that we’re after,” Farhadi said, explaining Ai2’s ambitions for 2025 on the GeekWire Podcast. “If you’re actually trying to solve a real problem, there is no turnkey solution.”The Cancer AI Alliance has said it expects initial research results by the end of 2025

GeekWire
Mar 18th, 2025
Geekwire Awards: Health Innovation Of The Year Field Is Dominated By Finalists Battling Cancer

The 2025 GeekWire Award finalists for Health Innovation of the Year are dominated by ventures that aim to outwit cancer with groundbreaking new technologies. The contenders range from a newly formed startup to a leading U.S. cancer institute and companies in between. Joining the cohort is a business with technology to help healthcare providers better manage appointments and access to providers.This awards category recognizes pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for improving peoples’ lives and enhancing the healthcare system.The finalists are Archon Biosciences, DexCare, Fred Hutch Cancer Center, Talus Bioscience and Umoja Biopharma.Last year’s winner was CalmWave, a Seattle health-tech startup that created a system for making sense of the alarms triggered by the devices that monitor hospital ICU patients.Continue reading for details on each of this year’s finalists, and vote here or below.Archon BiosciencesArchon Biosciences emerged from stealth last October with $20 million in funding. The Seattle biotech company is running with technology developed in the lab of University of Washington biochemist and Nobel Prize winner David Baker.Archon’s proprietary protein structures, known as Antibody Cages or AbCs, combine two biomedical tools — naturally occurring antibodies and custom-designed proteins — to create a single new protein structure. These protein structures, or AbCs, are optimized with the aid of generative AI to travel in the body in controllable ways and engage with target cells in a more specific manner.“What we like to say is, it’s not whether you’re given a drug, it’s how you’re given it,” said CEO and co-founder James Lazarovits

GeekWire
Mar 12th, 2025
Tech Moves: Longtime Google Leader Umesh Shankar Joins Microsoft As New Corporate Vp

Umesh Shankar. (LinkedIn Photo). After nearly 19 years at Google, Umesh Shankar has joined Microsoft AI as a corporate vice president of engineering.Shankar, based in New York City, has focused his career on privacy and security. His last role at Google was chief technologist and distinguished engineer for Google Cloud Security. Shankar will lead a new privacy and security engineering effort focused on Microsoft’s Copilot AI assistant, according to Microsoft AI CEO Mustafa Suleyman.“I believe that investing in a secure technical foundation will actually allow us to innovate with AI faster than we could in a world where giving AI more data and tools comes with unknown or unbounded risk,” he said on LinkedIn. “That’s why I’ll be focusing on building systems and platforms that have strong protections and user control built in.”Shankar is the latest Google leader to join Microsoft AI in recent months

INACTIVE